M Kathleen Behrens - Net Worth and Insider Trading

M Kathleen Behrens Net Worth

The estimated net worth of M Kathleen Behrens is at least $21 Million dollars as of 2024-11-13. M Kathleen Behrens is the Director of Sarepta Therapeutics Inc and owns about 140,517 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $16 Million. M Kathleen Behrens is also the Director of IGM Biosciences Inc and owns about 394,881 shares of IGM Biosciences Inc (IGMS) stock worth over $4 Million. Details can be seen in M Kathleen Behrens's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that M Kathleen Behrens has not made any transactions after 2023-06-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of M Kathleen Behrens

To

M Kathleen Behrens Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, M Kathleen Behrens owns 3 companies in total, including MiMedx Group Inc (MDXG) , IGM Biosciences Inc (IGMS) , and Sarepta Therapeutics Inc (SRPT) .

Click here to see the complete history of M Kathleen Behrens’s form 4 insider trades.

Insider Ownership Summary of M Kathleen Behrens

Ticker Comapny Transaction Date Type of Owner
MDXG MiMedx Group Inc 2019-06-19 director
IGMS IGM Biosciences Inc 2023-06-26 director
SRPT Sarepta Therapeutics Inc 2021-03-10 director

M Kathleen Behrens Latest Holdings Summary

M Kathleen Behrens currently owns a total of 2 stocks. Among these stocks, M Kathleen Behrens owns 140,517 shares of Sarepta Therapeutics Inc (SRPT) as of March 10, 2021, with a value of $16 Million and a weighting of 78.14%. M Kathleen Behrens also owns 394,881 shares of IGM Biosciences Inc (IGMS) as of June 26, 2023, with a value of $4 Million and a weighting of 21.86%.

Latest Holdings of M Kathleen Behrens

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SRPT Sarepta Therapeutics Inc 2021-03-10 140,517 114.29 16,059,688
IGMS IGM Biosciences Inc 2023-06-26 394,881 11.38 4,493,746

Holding Weightings of M Kathleen Behrens


M Kathleen Behrens Form 4 Trading Tracker

According to the SEC Form 4 filings, M Kathleen Behrens has made a total of 1 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Sarepta Therapeutics Inc is the sale of 5,000 shares on March 10, 2021, which brought M Kathleen Behrens around $428,800.

According to the SEC Form 4 filings, M Kathleen Behrens has made a total of 6 transactions in IGM Biosciences Inc (IGMS) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in IGM Biosciences Inc is the acquisition of 112,500 shares on June 26, 2023, which cost M Kathleen Behrens around $900,000.

Insider Trading History of M Kathleen Behrens

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

M Kathleen Behrens Trading Performance

GuruFocus tracks the stock performance after each of M Kathleen Behrens's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by M Kathleen Behrens is 22.37%. GuruFocus also compares M Kathleen Behrens's trading performance to market benchmark return within the same time period. The performance of stocks bought by M Kathleen Behrens within 3 months outperforms 8 times out of 12 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how M Kathleen Behrens's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of M Kathleen Behrens

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
6 out of 12 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 21.23 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 19.85 LIMIT LIMIT LIMIT LIMIT LIMIT

M Kathleen Behrens Ownership Network

Ownership Network List of M Kathleen Behrens

No Data

Ownership Network Relation of M Kathleen Behrens

Insider Network Chart

M Kathleen Behrens Owned Company Details

What does MiMedx Group Inc do?

Who are the key executives at MiMedx Group Inc?

M Kathleen Behrens is the director of MiMedx Group Inc. Other key executives at MiMedx Group Inc include General Counsel Hulse William Frank Iv , Chief Operating Officer Ricci S Whitlow , and Chief Financial Officer Rice Doug .

MiMedx Group Inc (MDXG) Insider Trades Summary

Over the past 18 months, M Kathleen Behrens made no insider transaction in MiMedx Group Inc (MDXG). Other recent insider transactions involving MiMedx Group Inc (MDXG) include a net sale of 61,807 shares made by Ricci S Whitlow , a net purchase of 100,000 shares made by Joseph H Capper , and a net sale of 20,381 shares made by Hulse William Frank Iv .

In summary, during the past 3 months, insiders sold 0 shares of MiMedx Group Inc (MDXG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 96,160 shares of MiMedx Group Inc (MDXG) were sold and 105,000 shares were bought by its insiders, resulting in a net purchase of 8,840 shares.

MiMedx Group Inc (MDXG)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

MiMedx Group Inc Insider Transactions

No Available Data

M Kathleen Behrens Mailing Address

Above is the net worth, insider trading, and ownership report for M Kathleen Behrens. You might contact M Kathleen Behrens via mailing address: 6701 Kaiser Drive, Fremont Ca 94555.